Dr David Ira Papish, DO | |
101 E Ross St, Clearwater, KS 67026-7824 | |
(620) 584-2055 | |
(620) 584-2032 |
Full Name | Dr David Ira Papish |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 101 E Ross St, Clearwater, Kansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194831362 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 05-18527 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David Ira Papish, DO 101 E Ross St, Po Box 308, Clearwater, KS 67026-7824 Ph: (620) 584-2055 | Dr David Ira Papish, DO 101 E Ross St, Clearwater, KS 67026-7824 Ph: (620) 584-2055 |
News Archive
Surgeons have devised a system to help determine the severity of high nipple-areola complex in patients after cosmetic or reconstructive breast surgery.
Many of the companies with the largest number of employees say they'll do almost anything to encourage their employees to get vaccinated.
New research funded by the British Heart Foundation (BHF) could pave the way for developing a test to predict pre-eclampsia in pregnant women and save the lives of mothers and babies across the world.
Patients with cancer and their caregivers have a new resource to help them navigate the maze of treatment options that they often confront. Today at the NCCN Patient Advocacy Summit in Washington D.C., the National Comprehensive Cancer Network launched its new series of NCCN Guidelines for Patients, consumer-friendly translations of the NCCN Clinical Practice Guidelines in Oncology outlining appropriate cancer treatment.
Older patients with breast cancer may benefit from adjuvant treatment with oral bisphosphonates, but further studies are needed before general application in the breast cancer population, say researchers.
› Verified 9 days ago